Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,196.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 1,208.50
  • 52 Week Low: 896.20
  • Currency: UK Pounds
  • Shares Issued: 874.37m
  • Volume: 2,426,869
  • Market Cap: £10,458m
  • RiskGrade: 173
  • Beta: 0.01

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.4% 0.0%
Div Cover 2.2 2.5
Op Mrgn 7.7% 15.9%
ROCE 9.1%  
Latest F'cast
P/E 18.9 17.1
PEG 15.5 n/a
Pr/Revenue 2.5 1.8
Pr/Book 2.6  
Latest F'cast
Revenue 6.4% -20.2%
PBT 23.4% 143.3%
EPS 1.2% -15.4%
DPS n/a -42.2%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 23.5 23.5 +1% 37.50¢ 1.6%
31-Dec-20 4,560.00 246.00 64.60¢ 30.7 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 21.0 0.8 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 17.8 17.8 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 17.1 17.1 +1% 37.50¢ 2.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,816.36 926.51 70.02p 17.1 n/a -15% 28.45p 0.0%
31-Dec-25 6,129.78 1,093.53 83.67p 14.3 0.7 +20% 32.25p 0.0%
31-Dec-26 6,442.47 1,198.18 93.57p 12.8 1.1 +12% 35.64p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Director/PDMR Shareholding 13-Sep-2024 15:16 RNS
Total Voting Rights 02-Sep-2024 16:11 RNS
Director/PDMR Shareholding 30-Aug-2024 10:38 RNS

Smith and Nephew ShareCast News

Sunday newspaper round-up: Hezbollah, Economic p... 25-Aug-2024 ShareCast
London close: Stocks slide as Bank of England tr... 01-Aug-2024 ShareCast
Smith & Nephew H1 profits come in ahead of expec... 01-Aug-2024 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,196.00p
Change Today -0.50p
% Change -0.04 %
52 Week High 1,208.50
52 Week Low 896.20
Volume 2,426,869
Shares Issued 874.37m
Market Cap £10,458m
Beta 0.01
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.99% below the market average90.99% below the market average90.99% below the market average90.99% below the market average90.99% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Trend
54.14% above the market average54.14% above the market average54.14% above the market average54.14% above the market average54.14% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Income
51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average51.11% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.87% below the market average36.87% below the market average36.87% below the market average36.87% below the market average36.87% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 6
Sell 0
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-24 28-Mar-24
Paid 08-Nov-24 22-May-24
Amount 14.40¢ 23.10¢

Trades for 13-Sep-2024

Time Volume / Share Price
16:50 7,974 @ 1,195.94p
16:50 7,974 @ 1,196.18p
16:50 6,433 @ 1,195.94p
16:50 6,433 @ 1,196.18p
16:50 6,412 @ 1,195.94p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page